Browsing "1. College of Medicine (의과대학)" by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 6601 to 6620 of 61716

This table browses all dspace content
Issue DateTitleJournal Title
2008Breast-feeding in South Korea: Factors influencing its initiation and durationPUBLIC HEALTH NUTRITION
2023Breastfeeding and impact on childhood hospital admissions: a nationwide birth cohort in South Korea NATURE COMMUNICATIONS
2021Breastfeeding and weaning practices among mothers in Ghana: A population-based cross-sectional study PLOS ONE
1996Breath-Hold MR Imaging of Focal Hepatic Lesions: Clinical Usefulness of Breath-Hold TSE T2WI Combined by Fast Low-Angle Shot (FLASH) MR Imaging Journal of the Korean Radiologist Society(대한방사선의학회지)
2023Breathing-Associated Facial Region Segmentation for Thermal Camera-Based Indirect Breathing Monitoring IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE
2023Breathing-Driven Self-Powered Pyroelectric ZnO Integrated Face Mask for BioprotectionSMALL
2019Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activationFASEB JOURNAL
2011Brevundimonas diminuta의 가성유행(Pseudo-outbreak) Korean Journal of Clinical Microbiology (대한임상미생물학회지)
2023Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines FRONTIERS IN IMMUNOLOGY
2023Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC JOURNAL OF THORACIC ONCOLOGY
2021Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib JTO Clinical and Research Reports
2019Brief Report: Malignancies in Adults Living With HIV in AsiaJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2022Brigatinib (BRG) vs crizotinib (CRZ) in anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor-naive ALK+ non-small cell lung cancer (NSCLC): ALTA-1L final resultsANNALS OF ONCOLOGY
2020Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L TrialJOURNAL OF CLINICAL ONCOLOGY
2021Brigatinib Versus Crizotinib in ALK Inhibitor-Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial JOURNAL OF THORACIC ONCOLOGY
2018Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung CancerNew England Journal of Medicine
2013Bright illumination reduces parietal EEG alpha activity during a sustained attention task BRAIN RESEARCH
2007Brimonidine 0.2% versus brimonidine purite 0.15% in Asian ocular hypertensionJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
2006Brimonidine 0.2% Versus Brimonidine Purite 0.15%: Prophylactic Effect on IOP Elevation After Nd:YAG Laser Posterior CapsulotomyJOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
2015Brimonidine reduces TGF-beta-induced extracellular matrix synthesis in human Tenon's fibroblasts BMC OPHTHALMOLOGY

Browse

Links